The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Showing 1-9 of 9 articles
How should I treat a coronary artery to pulmonary artery fistula at an acute stent thrombosis site?
December 20, 2017 | 10.4244/EIJ-D-16-00903
Long-term clinical outcomes after percutaneous coronary intervention versus coronary artery bypass grafting for acute coronary syndrome from the DELTA registry: a multicentre registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment
Pyxaras SA,
Hunziker L,
Chieffo A,
Meliga E,
Latib A,
Park S,
Onuma Y,
Capranzano P,
Valgimigli M,
Narbute I,
Makkar R,
Palacios I,
Kim Y,
Buszman P,
Chakravarty T,
Sheiban I,
Mehran R,
Margey R,
Agnihotri A,
Marra S,
Capodanno D,
Leon M,
Moses J,
Fajadet J,
Lefèvre T,
Morice M,
Erglis A,
Tamburino C,
Alfieri O,
Serruys P,
Colombo A,
Naber C
August 5, 2016 | 10.4244/EIJV12I5A102
Coronary artery bypass graft versus percutaneous coronary intervention with drug-eluting stent implantation for diabetic patients with unprotected left main coronary artery disease: the D-DELTA registry
Meliga E,
De Benedictis M,
Chieffo A,
Latib A,
Park S,
Kim Y,
Onuma Y,
Capranzano P,
Jegere S,
Makkar R,
Palacios I,
Buszman P,
Bande M,
Chakravarty T,
Mehran R,
Naber C,
Scrocca I,
Margey R,
Leon M,
Moses J,
Fajadet J,
Lefèvre T,
Morice M,
Erglis A,
Tamburino C,
Alfieri O,
Conte M,
Serruys P,
Colombo A
November 29, 2013 | 10.4244/EIJV9I7A133
Percutaneous coronary intervention with oral sirolimus and bare metal stents has comparable safety and efficacy to treatment with drug eluting stents, but with significant cost saving: long-term follow-up results from the randomised, controlled ORAR III (Oral Rapamycin in ARgentina) study Alfredo E.
Rodriguez A,
Maree A,
Tarragona S,
Fernandez-Pereira C,
Santaera O,
Granillo R,
Rodríguez-Granillo G,
Russo-Felssen M,
Kukreja N,
Antoniucci D,
Palacios I,
Serruys P
June 30, 2009 | 10.4244/EIJV5I2A40
Diabetic patients treated for unprotected left main coronary artery disease with drug eluting stents: a 3-year clinical outcome study. The Diabetes and Drug Eluting stent for LeFT main registry (D-DELFT)
Meliga E,
Garcia-Garcia HM,
Valgimigli M,
Chieffo A,
Biondi-Zoccai G,
O’ Maree A,
Gonzalo N,
Cook S,
Cruz-González I,
Marra S,
De Servi S,
Palacios I,
Windecker S,
van Domburg R,
Colombo A,
Sheiban I,
Serruys P
May 13, 2008
Revascularization strategies of coronary multiple vessel disease in the Drug Eluting Stent Era: one year follow-up results of the ERACI III Trial
Rodriguez A,
O’ Maree A,
Grinfeld L,
Fernandez-Pereira C,
Mieres J,
Alemparte MR,
Berrocal D,
Rodríguez-Granillo G,
Vigo C,
Felsen M,
O’ Neill W,
Palacios I
May 20, 2006
Latest news
AHEAD OF PRINT
LVOT calcification in TAVI : a post hoc analysis from the SOLVE-TAVI trial
FREE ARTICLE - Serdar Farhan et al
August 9, 2022
NEW ISSUE
The 16th EBC Expert consensus; ticagrelor or aspirin monotherapy 1 year after PCI; vasospasm and atherosclerosis in ANOCA; lifetime valve journey; and more…
August 5, 2022
AHEAD OF PRINT
RADIANCE-HTN SOLO 36-month analysis
FREE ARTICLE - Florian Rader et al
August 1, 2022
AHEAD OF PRINT
Percutaneous left atrial appendage closure with superior vascular access
FREE ARTICLE - Roberto Galea et al
August 4, 2022
AHEAD OF PRINT
Dual ProGlide vs ProGlide and FemoSeal after TAVI
FREE ARTICLE - Jonas M.D. Gmeiner et al
July 29, 2022
AHEAD OF PRINT
Stent thrombosis in comatose OHCA (ST-OHCA Study)
FREE ARTICLE - Martin Rauber et al
July 25, 2022
AHEAD OF PRINT
Evolocumab and periprocedural microvascular damage
FREE ARTICLE - Masaharu Ishihara et al
July 15, 2022